Roberta Bertorelle Selected Research

Rectal Neoplasms (Rectal Cancer)

1/2018	The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
1/2018	Author Correction: The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
4/2011	Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberta Bertorelle Research Topics

Disease

16	Neoplasms (Cancer) 09/2023 - 05/2007
4	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 05/2008
4	Disease Progression 12/2020 - 02/2014
4	Glioma (Gliomas) 05/2015 - 03/2007
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023 - 01/2022
3	Hairy Cell Leukemia 01/2023 - 12/2017
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 04/2011
2	Leukemia 09/2023 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2023 - 01/2018
2	Lymphoma (Lymphomas) 01/2023 - 12/2020
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 01/2020
2	Hypertension (High Blood Pressure) 01/2018 - 01/2013
2	Hypoxia (Hypoxemia) 01/2017 - 04/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 12/2010
2	Adenocarcinoma of Lung 11/2015 - 12/2010
2	Colorectal Neoplasms (Colorectal Cancer) 02/2014 - 11/2008
2	Neuroblastoma 07/2012 - 06/2008
1	Proteinuria 04/2024
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2023
1	Monoclonal Gammopathy of Undetermined Significance 01/2023
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Primary Myelofibrosis (Myelosclerosis) 01/2022
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Essential Thrombocythemia 10/2019
1	Pheochromocytoma 01/2018
1	Paraganglioma (Paragangliomas) 01/2018
1	T-Cell Leukemia (Leukemia, T Cell) 01/2018
1	Necrosis 01/2017
1	Hypopituitarism (Sheehan's Syndrome) 03/2015
1	Cushing Syndrome 03/2015
1	Pituitary Neoplasms (Pituitary Adenoma) 03/2015
1	Cardiomyopathies (Cardiomyopathy) 09/2014
1	Genomic Instability 02/2014
1	Pathologic Complete Response 02/2014
1	Infections 11/2013
1	Multiple Myeloma 10/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2013
1	Adenocarcinoma 12/2010

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 05/2022 - 10/2006
5	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2006
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 08/2007
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 04/2011
2	Monoclonal AntibodiesIBA 09/2023 - 10/2019
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 12/2010
2	MethyltransferasesIBA 05/2022 - 10/2006
2	O-(6)-methylguanineIBA 05/2022 - 10/2006
2	ibrutinibIBA 12/2020 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2013
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2018
2	Bevacizumab (Avastin)FDA Link 01/2017 - 01/2012
2	Adenosine Triphosphate (ATP)IBA 01/2015 - 10/2013
2	Messenger RNA (mRNA)IBA 02/2014 - 11/2008
2	Codon (Codons)IBA 02/2014 - 07/2012
1	CreatinineIBA 04/2024
1	UbiquitinIBA 09/2023
1	Ligases (Synthetase)IBA 09/2023
1	AntimetabolitesIBA 09/2023
1	Imatinib Mesylate (Gleevec)FDA Link 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	venetoclaxIBA 12/2020
1	purineIBA 12/2020
1	Myelin-Associated GlycoproteinIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	CalreticulinIBA 10/2019
1	CatecholaminesIBA 01/2018
1	embelinIBA 01/2018
1	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2018
1	Bendamustine Hydrochloride FDA Link 12/2017
1	Rituximab (Mabthera)FDA Link 12/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2015
1	alpha-hydroxyglutarateIBA 05/2015
1	pasireotideIBA 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	Oxygen (Dioxygen)IBA 01/2015
1	Mitotane (Lysodren)FDA Link 09/2014
1	MyogeninIBA 02/2014
1	Oncogene Proteins (Oncogene Protein)IBA 11/2013
1	immune RNA (I-RNA)IBA 11/2013
1	AntibodiesIBA 11/2013
1	silmitasertibIBA 10/2013
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2013
1	Phosphotransferases (Kinase)IBA 10/2013
1	Casein Kinase II (Casein Kinase 2)IBA 10/2013
1	Angiogenesis InhibitorsIBA 01/2013
1	Tumor Biomarkers (Tumor Markers)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	prolyl-proline (Pro-Pro)IBA 07/2012
1	arginylprolineIBA 07/2012
1	arginylarginine (Arg-Arg)IBA 07/2012
1	Protein Isoforms (Isoforms)IBA 07/2012
1	CilengitideIBA 01/2012

Therapy/Procedure

12	Therapeutics 12/2023 - 03/2004
4	Drug Therapy (Chemotherapy) 09/2023 - 05/2008
4	Chemoradiotherapy 05/2022 - 05/2008
4	Radiotherapy 10/2015 - 10/2006
1	Aftercare (After-Treatment) 01/2020
1	Neoadjuvant Therapy 01/2018
1	Adjuvant Chemotherapy 11/2015